Peapack-Gladstone Financial Corp’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3M Sell
30,321
-838
-3% -$75.5K 0.03% 306
2026
Q1
$2.7M Sell
31,159
-304
-1% -$26.6K 0.03% 306
2025
Q4
$2.67M Sell
31,463
-758
-2% -$60.5K 0.03% 312
2025
Q3
$2.34M Sell
32,221
-614
-2% -$42.4K 0.03% 325
2025
Q2
$2.15M Sell
32,835
-1,259
-4% -$82K 0.03% 323
2025
Q1
$2.41M Sell
34,094
-3,468
-9% -$241K 0.04% 307
2024
Q4
$2.47M Sell
37,562
-2,945
-7% -$203K 0.04% 298
2024
Q3
$2.86M Sell
40,507
-869
-2% -$60.6K 0.04% 297
2024
Q2
$2.74M Sell
41,376
-3,011
-7% -$197K 0.04% 289
2024
Q1
$3.01M Sell
44,387
-1,510
-3% -$99.8K 0.05% 273
2023
Q4
$2.84M Sell
45,897
-927
-2% -$54.5K 0.05% 267
2023
Q3
$2.76M Sell
46,824
-585
-1% -$35.9K 0.05% 259
2023
Q2
$2.83M Sell
47,409
-3,261
-6% -$194K 0.05% 263
2023
Q1
$3.16M Buy
50,670
+360
+0.7% +$21.7K 0.06% 251
2022
Q4
$3.12M Sell
50,310
-810
-2% -$48.7K 0.06% 255
2022
Q3
$2.89M Buy
+51,120
New +$3.15M 0.06% 255

Other funds holding IHE

Peapack-Gladstone Financial Corp's IHE Position: Q2 2026 in Review

Peapack-Gladstone Financial Corp reduced its iShares US Pharmaceuticals ETF (IHE) stake by 2.7% in Q2 2026, selling an estimated $75.5K and leaving 30,321 shares worth $3M. The position accounts for 0.03% of the portfolio, ranked #306.

Peapack-Gladstone Financial Corp first reported a position in IHE in Q3 2022 and has held it in 16 quarters since. The position peaked at $3.16M in Q1 2023. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • Peapack-Gladstone Financial Corp held 30,321 shares of iShares US Pharmaceuticals ETF worth $3M as of Q2 2026.
  • Peapack-Gladstone Financial Corp sold 838 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $75.5K.
  • iShares US Pharmaceuticals ETF made up 0.03% of Peapack-Gladstone Financial Corp's portfolio in Q2 2026, its #306 holding.
  • Peapack-Gladstone Financial Corp first reported a position in iShares US Pharmaceuticals ETF in Q3 2022 and has held it in 16 quarters since.
  • Peapack-Gladstone Financial Corp's iShares US Pharmaceuticals ETF position peaked at $3.16M in Q1 2023.
  • 209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q2 2026, filed 14 Aug 2026.